Diagnosis, localization, and treatment of primary aldosteronism.
PA should be suspected in any hypertensive patient with evidence of renin suppression and should be confirmed by demonstration of inappropriate and excessive aldosterone production. Preoperative differentiation of unilateral and bilateral forms of the syndrome should be pursued to identify those patients most likely to benefit from surgical intervention. In patients with apparent bilateral disease, specific medical therapy should be pursued.
D000450:Aldosterone / Q000097:blood; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002404:Catheterization; D003937:Diagnosis, Differential; D006801:Humans; D006929:Hyperaldosteronism / Q000175:diagnosis* / Q000601:surgery / Q000628:therapy; D011877:Radionuclide Imaging; D012083:Renin / Q000097:blood; D013148:Spironolactone / Q000627:therapeutic use
D000959:Antihypertensive Agents; D013148:Spironolactone; D000450:Aldosterone; D012083:Renin